Financhill
Sell
24

TROW Quote, Financials, Valuation and Earnings

Last price:
$94.05
Seasonality move :
3.57%
Day range:
$93.34 - $94.76
52-week range:
$91.37 - $125.81
Dividend yield:
5.33%
P/E ratio:
10.22x
P/S ratio:
2.95x
P/B ratio:
2.01x
Volume:
1.8M
Avg. volume:
1.8M
1-year change:
-18.1%
Market cap:
$20.8B
Revenue:
$7.1B
EPS (TTM):
$9.16

Analysts' Opinion

  • Consensus Rating
    T. Rowe Price Group has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 9 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $109.79, T. Rowe Price Group has an estimated upside of 17.29% from its current price of $94.05.
  • Price Target Downside
    According to analysts, the lowest downside price target is $90.00 representing 100% downside risk from its current price of $94.05.

Fair Value

  • According to the consensus of 10 analysts, T. Rowe Price Group has 17.29% upside to fair value with a price target of $109.79 per share.

TROW vs. S&P 500

  • Over the past 5 trading days, T. Rowe Price Group has underperformed the S&P 500 by -2.79% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • T. Rowe Price Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • T. Rowe Price Group has grown year-over-year revenues for 7 quarters straight. In the most recent quarter T. Rowe Price Group reported revenues of $1.8B.

Earnings Growth

  • T. Rowe Price Group has grown year-over-year earnings for 7 quarters straight. In the most recent quarter T. Rowe Price Group reported earnings per share of $1.92.
Enterprise value:
19.3B
EV / Invested capital:
1.69x
Price / LTM sales:
2.95x
EV / EBIT:
7.79x
EV / Revenue:
2.72x
PEG ratio (5yr expected):
0.57x
EV / Free cash flow:
15.29x
Price / Operating cash flow:
16.56x
Enterprise value / EBITDA:
6.34x
Gross Profit (TTM):
$3.7B
Return On Assets:
16.06%
Net Income Margin (TTM):
29.61%
Return On Equity:
19.29%
Return On Invested Capital:
19.29%
Operating Margin:
32.88%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $6.5B $6.5B $7.1B $1.6B $1.8B
Gross Profit $3.6B $3.2B $3.7B $762.8M $947.6M
Operating Income $2.5B $2B $2.5B $418.7M $599.8M
EBITDA $3.1B $2.6B $3B $718.7M $915.6M
Diluted EPS $6.69 $7.76 $9.16 $1.90 $1.92
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $3B $2.6B $2.5B $2.9B $3.5B
Total Assets $10.7B $12.5B $11.6B $12.3B $13.5B
Current Liabilities $272.7M $508.9M $452.7M $489.1M $440.6M
Total Liabilities $1.4B $2.3B $2B $2B $2B
Total Equity $9.3B $10.3B $9.7B $10.3B $11.5B
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $2.4B $1.2B $1.7B -$157.4M -$281.9M
Cash From Investing -$41.5M $128.2M -$177.5M $90.1M -$22.5M
Cash From Financing -$2.1B -$1.1B -$936.6M -$461.4M -$208.4M
Free Cash Flow $2.1B $911.2M $1.3B -$239.3M -$394.9M
TROW
Sector
Market Cap
$20.8B
$618.6M
Price % of 52-Week High
74.4%
85.59%
Dividend Yield
5.33%
2.01%
Shareholder Yield
5.72%
3.87%
1-Year Price Total Return
-18.63%
9.44%
Beta (5-Year)
1.465
0.715
Dividend yield:
5.33%
Annualized payout:
$4.96
Payout ratio:
54.07%
Growth streak:
2 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $94.66
200-day SMA
Sell
Level $111.95
Bollinger Bands (100)
Sell
Level 104.96 - 120.42
Chaikin Money Flow
Buy
Level 355.8M
20-day SMA
Sell
Level $100.61
Relative Strength Index (RSI14)
Sell
Level 30.19
ADX Line
Sell
Level 44.56
Williams %R
Buy
Level -85.6776
50-day SMA
Sell
Level $107.70
MACD (12, 26)
Sell
Level -4.51
25-day Aroon Oscillator
Sell
Level -88
On Balance Volume
Neutral
Level 157.1M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (9.9342)
Buy
CA Score (Annual)
Level (1.8617)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-6.2932)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of October 2024, the firm had $1.607 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.

Stock Forecast FAQ

In the current month, TROW has received 0 Buy ratings 9 Hold ratings, and 1 Sell ratings. The TROW average analyst price target in the past 3 months is $109.79.

  • Where Will T. Rowe Price Group Stock Be In 1 Year?

    According to analysts, the consensus estimate is that T. Rowe Price Group share price will rise to $109.79 per share over the next 12 months.

  • What Do Analysts Say About T. Rowe Price Group?

    Analysts are divided on their view about T. Rowe Price Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that T. Rowe Price Group is a Buy and believe this share price will drop from its current level to $125.00.

  • What Is T. Rowe Price Group's Price Target?

    The price target for T. Rowe Price Group over the next 1-year time period is forecast to be $109.79 according to 10 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.

  • Is TROW A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for T. Rowe Price Group is a Hold. 9 of 10 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of TROW?

    You can purchase shares of T. Rowe Price Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase T. Rowe Price Group shares.

  • What Is The T. Rowe Price Group Share Price Today?

    T. Rowe Price Group was last trading at $94.05 per share. This represents the most recent stock quote for T. Rowe Price Group. Yesterday, T. Rowe Price Group closed at $94.05 per share.

  • How To Buy T. Rowe Price Group Stock Online?

    In order to purchase T. Rowe Price Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 20

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 35.1% over the past day.

Sell
50
SRPT alert for Mar 20

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock